| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 哈尔滨誉衡药业股份有限公司是一家从事药品生产及销售的公司.其主要产品有小容量注射剂、冻干粉针剂(含抗肿瘤药、头孢菌素类)、片剂、胶囊剂、颗粒剂(均为头孢菌素类)、栓剂、粉针剂(头孢菌素类),主导产品为鹿瓜多肽注射液和注射用盐酸吉西他滨.公司核心产品鹿瓜多肽注射液获得国家发明专利,并进入全国医保目录,2007年该产品获得国家发改委单独定价权,2008年占同类药品市场份额超过65%,具有较强品牌优势和竞争力,其"松梅乐"商标被评为黑龙江省著名商标。 | ||||||||||||||||||||||||
| Main Business | 主要从事药品的研发、生产和销售 | ||||||||||||||||||||||||
| Legal Representative | 胡晋 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 刘月寅 | ||||||||||||||||||||||||
| Solicitors | 北京市君合律师事务所 | ||||||||||||||||||||||||
| Auditors | 利安达会计师事务所有限责任公司 | ||||||||||||||||||||||||
| Tel No | 010-80479607;010-68002437-8018 | ||||||||||||||||||||||||
| Fax No | 010-68002438-607 | ||||||||||||||||||||||||
| Website | www.gloria.cc | ||||||||||||||||||||||||
| irm@gloria.cc;liuyueyin@gloria.cc;baixuelong@gloria.cc | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 23/06/2010 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.055 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 0.756 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 4.710B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |